Literature DB >> 29398483

Taking a Hint from Structural Biology: To Better Understand AAV Transport across the BBB.

Dan Wang1, Guangping Gao2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29398483      PMCID： PMC5835224          DOI： 10.1016/j.ymthe.2018.01.005

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  AAV capsid structure and cell interactions.

Authors:  Mavis Agbandje-McKenna; Jürgen Kleinschmidt
Journal:  Methods Mol Biol       Date:  2011

2.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

3.  Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

Authors:  Roberto Calcedo; Luk H Vandenberghe; Guangping Gao; Jianping Lin; James M Wilson
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

4.  Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.

Authors:  Steven F Merkel; Allison M Andrews; Evan M Lutton; Dakai Mu; Eloise Hudry; Bradley T Hyman; Casey A Maguire; Servio H Ramirez
Journal:  J Neurochem       Date:  2016-12-15       Impact factor: 5.372

5.  Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system.

Authors:  Hongwei Zhang; Bin Yang; Xin Mu; Seemin Seher Ahmed; Qin Su; Ran He; Hongyan Wang; Christian Mueller; Miguel Sena-Esteves; Robert Brown; Zuoshang Xu; Guangping Gao
Journal:  Mol Ther       Date:  2011-05-24       Impact factor: 11.454

6.  Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion.

Authors:  Longping Victor Tse; Kelli A Klinc; Victoria J Madigan; Ruth M Castellanos Rivera; Lindsey F Wells; L Patrick Havlik; J Kennon Smith; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

7.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

Review 8.  Engineering AAV receptor footprints for gene therapy.

Authors:  Victoria J Madigan; Aravind Asokan
Journal:  Curr Opin Virol       Date:  2016-06-02       Impact factor: 7.090

9.  Adeno-associated virus structural biology as a tool in vector development.

Authors:  Lauren M Drouin; Mavis Agbandje-McKenna
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

10.  Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.

Authors:  Benjamin E Deverman; Piers L Pravdo; Bryan P Simpson; Sripriya Ravindra Kumar; Ken Y Chan; Abhik Banerjee; Wei-Li Wu; Bin Yang; Nina Huber; Sergiu P Pasca; Viviana Gradinaru
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908
View more
  1 in total

1.  Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates.

Authors:  Jeff L Ellsworth; Jacinthe Gingras; Laura J Smith; Hillard Rubin; Tania A Seabrook; Kruti Patel; Nicole Zapata; Kevin Olivieri; Michael O'Callaghan; Elizabeth Chlipala; Pablo Morales; Albert Seymour
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.